The 230-acre site in Sanford, North Carolina, just south of the famed Research Triangle, is home to one of the largest U.S. biotechnology hubs. The site has flexible, multi-product manufacturing capabilities and facilities focused on vaccines intermediates and drug substance, and gene therapy drug substance and drug product.
The vaccine manufacturing capabilities center on large-scale microbial fermentation, purification, conjugation and cell banking. Gene therapy capabilities include cell culture, purification, drug product formulation and filling, and inspect, label and primary packaging.
Sanford has been certified as a Carolina STAR site since 2007; the equivalent of an OSHA VPP certification recognizing safety excellence.
In 2017, Pfizer invested $100 million in a state-of-the-art gene therapy facility where clinical trial material drug substances and drug products are produced for Duchenne Muscular Dystrophy, hemophilia B and hemophilia A gene therapy candidates. In 2019, Pfizer announced an additional investment of $500 million for the construction of its facility for the production of gene therapies.
Turning the Promise of Gene Therapy into a Reality
Read More
The 230-acre site in Sanford, just south of the famed Research Triangle, is home to one of the largest U.S. biotechnology hubs.
The Rocky Mount site is one of the largest sterile injectable facilities in the world, with more than 1.4 million square feet of manufacturing space on 250 acres in Eastern North Carolina.
In Rochester, King Pharmaceuticals, a subsidiary of Pfizer, manufactures and packages penicillin, the only approved treatment for late stage syphilis.
With more than 100 years of rich history in innovation and manufacturing excellence, 19 products- including various vaccines, antibiotics, and oncology medicines, have been discovered, developed, and approved at the Pearl River, New York site.
Since 1982, the Middleton site has focused on the manufacture of biologics. The 83,000-square-foot facility isolates bovine thrombin, a naturally occurring enzyme which plays a critical role in rapid clotting (hemostasis) of blood.
The McPherson site specializes in manufacturing sterile injectable medicines used daily in hospitals around the world.
The largest manufacturing site in the Pfizer network is located in Kalamazoo. This 1,300 acre facility manufactures active pharmaceutical ingredients (API), drug products (DP) and medical devices.
In Franklin, our 48,000-square-foot facility manufactures heparin active pharmaceutical ingredient (API).
